Global Head GMP/GDP Compliance, Corporate QA & General Manager ACINO AG Germany
Professional Overview
Antonios Karagiannidis is an accomplished pharmaceutical industry executive with extensive expertise in quality assurance, compliance, and operations management. As the Global Head of GMP/GDP Compliance and Corporate QA, as well as the General Manager of ACINO AG Germany, he is responsible for driving strategic initiatives and ensuring the highest standards of quality and regulatory compliance across the organization.
Experience Summary
Current Role
As the Global Head of GMP/GDP Compliance and Corporate QA at ACINO, Antonios oversees the implementation and maintenance of robust quality management systems, ensuring compliance with Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) across the company's global operations. In his role as General Manager of ACINO AG Germany, he is responsible for the overall management and strategic direction of the company's German subsidiary, driving operational excellence and business growth.
Career Progression
Prior to his current positions, Antonios held the role of Head of Supplier Quality Management at Novartis Technical Operations AICO, where he was instrumental in strengthening the company's supplier quality assurance program and optimizing the supply chain. He also has experience as a QA Compliance Manager Audits at Sandoz, where he played a key role in maintaining regulatory compliance and overseeing internal and external audits.
Academic Background
Antonios holds a postdoctoral degree from the University of Innsbruck and the Medical University of Innsbruck, where he conducted research in the field of pharmaceutical sciences.
Areas of Expertise
- Quality assurance and compliance management
- Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP)
- Supplier quality management and supply chain optimization
- Pharmaceutical operations and general management
- Project management and strategic planning
- Regulatory affairs and auditing
Professional Impact
Throughout his career, Antonios has demonstrated a strong commitment to driving operational excellence and upholding the highest standards of quality and compliance in the pharmaceutical industry. He has led initiatives that have resulted in improved supply chain efficiency, enhanced regulatory compliance, and strengthened quality management systems, contributing to the overall success and growth of the organizations he has served.
Conclusion
With his extensive experience, technical expertise, and proven track record of leadership, Antonios Karagiannidis is a valuable asset to the pharmaceutical industry. In his current roles at ACINO, he continues to drive innovation, foster a culture of quality, and deliver strategic solutions that create lasting impact for the company and its stakeholders.
